Hosted By SSI Strategy & Digital Therapeutics Alliance “It can be really daunting to young companies if you go out and get a quote for Medical Affairs work, or if you think about the people that you’re gonna have to hire. And you look at the 200 things in a launch playbook or something that … Read more
If we had to summarize this next Episode of the Emerging Biotech Leader in one sentence, it would be “a deeper dive on both the impact and importance of Medical Affairs,” inspired by our interview with Rachel Couchenour in Episode 13. But that single sentence alone wouldn’t convey the robust takeaways and mindset shift that … Read more
“I’ve found that it’s usually not the ‘what’ or the ‘how’ that will get me where I need to go with a Senior leader. It’s the why. They want to understand the why behind it.” Rachel Couchenour, VP, Global Medical Affairs, Travere Therapeutics. Working cross-functionally. Some would call it a skill. Others would say it’s … Read more
What if there were a way to genetically engineer fungi species and transform them into human therapeutics to help with neurological disorders? Today’s guest, Dr. Usman (Oz) Azam, just launched a biotech, Empyrean Neurosciences, that is genetically modifying fungi to create therapeutics. Biotech is hard enough as it is, but what does it take to … Read more